Role of APOE and Age at Enrollment in the Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

por Drye, Lea T., Zandi, Peter P.
Publicado 2012

Registration of phase 3 crossover trials on ClinicalTrials.gov

por Zeng, Lijuan, Qureshi, Riaz, Viswanathan, Shilpa, Drye, Lea, Li, Tianjing
Publicado 2020

The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial

por Scherer, Roberta W., Drye, Lea, Mintzer, Jacobo, Lanctôt, Krista, Rosenberg, Paul, Herrmann, Nathan, Padala, Prasad, Brawman-Mintzer, Olga, Burke, William, Craft, Suzanne, Lerner, Alan J., Levey, Allan, Porsteinsson, Anton, van Dyck, Christopher H.
Publicado 2018

Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial

por Drye, Lea T., Spragg, David, Devanand, D. P., Frangakis, Constantine, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Pollock, Bruce G., Porsteinsson, Anton P., Rabins, Peter V., Rosenberg, Paul B., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Yesavage, Jerome, Lyketsos, Constantine G.
Publicado 2014